PROTAC-based therapeutics for targeting HPV oncoproteins in head and neck cancers
The increasing incidence of Human Papillomavirus (HPV)-related head and neck cancers, particularly oropharyngeal squamous cell carcinomas, highlights the need for advanced therapeutic options beyond the traditional modalities of surgery, radiation, and chemotherapy, which often lead to significant m...
Saved in:
Main Authors: | Nobendu Mukerjee, Dattatreya Mukherjee |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2025-12-01
|
Series: | Nano TransMed |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2790676025000020 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential application of proteolysis targeting chimera (PROTAC) modification technology in natural products for their targeted protein degradation
by: Guliang Yang, et al.
Published: (2022-03-01) -
Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire
by: Scott Anderson, et al.
Published: (2017-10-01) -
PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development
by: Sanaul Mustafa, et al.
Published: (2025-01-01) -
Targeting ferroptosis for improved radiotherapy outcomes in HPV‐negative head and neck squamous cell carcinoma
by: Joo Kyung Noh, et al.
Published: (2025-02-01) -
Textbook of Head and Neck Anatomy /
by: Hiatt, James L., 1934-
Published: (2002)